The London-headquartered company entered into an agreement in 2023 with Cantor Fitzgerald & Co. to sell equity worth up to $100 million through an at-the-money program.
Incoming CEO Joakim Weidemanis held several executive leadership roles over his 13-year career at Danaher Corporation and most recently served as Executive Vice President of Diagnostics and China at Danaher.
Retail investors on Stocktwits debated whether GameStop’s latest stock rally is driven by genuine crypto ambitions or mere speculation following Ryan Cohen’s recent meeting.
Post Hotard’s departure, Intel’s AI business will be headed by Karin Eibschitz Segal in the interim as the company looks for a full-time replacement. Segal has recently led Intel’s Validation Engineering department.
Revenue rose nearly 7% year-over-year (YoY) to $4.55 billion during the quarter, while net income fell to $187 million compared to $446 million in the same quarter a year ago.
The drug, a proprietary encapsulated form of rapamycin, is being developed for familial adenomatous polyposis (FAP), a condition that, if left untreated, universally leads to colorectal cancer.
The tech firm’s pivot to digital assets drew mixed reactions, as its stock continues to hover near record lows following a 99.6% decline over the past year.
Argus notes that Nvidia’s AI chips are unmatched by competitors – the Jensen Huang-led company capitalized on its first-mover advantage to become the primary provider to major AI and cloud service providers.
According to a Barron’s report, the CFO also said that the strength of the U.S. dollar is a headwind to the firm’s growth, noting that the dollar is a bit stronger now than in late December.
The prospect of new trade restrictions has heightened concerns about inflation and potential trade wars, fueling demand for gold, traditionally seen as a hedge against economic and geopolitical instability.
According to a TechCrunch report, Japanese conglomerate Marubeni will own and finance the Mobileye-equipped vehicles that will reflect on Lyft’s ride-hailing app.
Cloudflare's fourth-quarter earnings beat analyst estimates, and despite a conservative outlook for fiscal 2025, brokerages have updated their price targets higher.
Cleveland-Cliffs’ stock surge follows optimism around U.S. President Trump’s protectionist trade policies that could shield U.S. steelmakers from foreign competition.
This comes after Strategy’s fourth-quarter results – the Michael Saylor co-founded company posted a wider-than-expected loss during this period at $3.03 per share versus an estimated EPS of $0.50.
The firm expects rent inflation to increase just one basis point in January with a 0.32% month-over-month print. Hotels, medical services, and car insurance are expected to accelerate, boosting core services ex-housing, it said.
With Amazon's exclusivity period now over, Rivian said it has been trialing the commercial van with several large fleets and refining its fleet management process.
CEO Hassane El-Khoury sought to reassure investors, emphasizing that ON Semiconductor remains structurally resilient despite current market volatility.
TSEM noted that it has stopped discontinued production of chips using the legacy and lower margin Fab 1 process – it has moved to the higher margin Fab 2 process now.
Under the settlement terms, Teva will receive a license to sell a generic version of Auvelity starting March 31, 2039, if pediatric exclusivity is granted.
Sales declined 8% year-over-year (YoY) to $1.88 billion, aligning with a Wall Street estimate. Adjusted earnings per share (EPS) came in at $1.83 versus an analyst estimate of $1.58.
The commercial aired Sunday night on Fox and positioned obesity as "America's deadliest epidemic" while criticizing the $160 billion weight-loss industry and the broader healthcare system.
Earnings, tariff concerns, AI partnerships, delivery milestones, and a high-profile merger standoff got Stocktwits users talking about these companies.
These five small-cap pharma and biotech stocks drew heavy attention on Stocktwits last week, driven by key trial results, FDA updates, and promising drug developments.
After Microsoft, Meta, Google and Amazon have reported an increase in AI-related spending, Astera Labs investors are looking for reassurance that AI-driven chip demand will remain strong in the coming year.
The week will witness the release of twin inflation readings, the retail sales report for January, and a deluge of speeches by Federal Reserve officials.
Analyst Steve Koenig expects Atlassian to maintain its 2025 momentum, citing the stability in the quarterly revenue trends and the proposed 15%-25% data center price increases.
The SEC declined to share correspondence between itself and the Department of Enforcement staff due to the potential harm it could cause to the ongoing enforcement proceeding.
President Donald Trump met with Japanese Prime Minister Shigeru Ishiba on Friday, and the U.S. Steel-Nippon Steel deal is likely to be discussed. Details of the meeting are yet to be disclosed.
The SEC's acknowledgment of a Solana ETF application and new XRP ETF filings have fueled speculation that both cryptocurrencies could be next in line for institutional adoption.
Despite the price target cut, Mizuho has maintained an ‘Outperform’ rating on the stock. The brokerage’s analysts believe that Synaptics’ revenue stream has stabilized and is past the trough now.
Revenue rose 6.1% year-over-year (YoY) to a record high of $140.68 million during the quarter, beating a Wall Street estimate of $133.96 million. Adjusted earnings per share (EPS) came in at $0.59 versus an analyst estimate of $0.51.
BigBear.ai stock has seen a massive jump this year of nearly 90%, and retail traders are now watching if it can break through resistance before the week ends.
According to Koyfin data, the company reported adjusted earnings of $0.25 per share for the fiscal first quarter, topping the average analysts’ estimate of $0.15 per share.
A Stocktwits poll shows that most retail investors dismissed Strategy’s software business as irrelevant to its valuation, reinforcing its identity as a leveraged Bitcoin vehicle.
The analyst noted that CAN-2409's early data in prostate cancer suggests the potential for a meaningful breakthrough, given the lack of significant advancements in available treatments.
The flooring company reported adjusted earnings of $1.95 per share for the three months ended Dec. 31, compared with the average analysts’ estimate of $1.85 per share.
Emerson said it will acquire all outstanding shares of common stock of Aspen Technology not already owned by it for $265 per share in cash, valuing the minority stake at $7.2 billion.
Frontier reported a 12% rise in its total operating revenue to a record billion dollars compared to a Wall Street estimate of $986.50 million. Adjusted earnings per share (EPS) came in at $0.23 compared to an analyst estimate of $0.13.
On an adjusted basis, the company reported $53.7 million, or $3.20 per share, for the three months ended Dec. 31, compared with the average analysts’ expectation of $1.64 per share.
The stock’s gains on Friday follow a sharp 3.3% decline in the previous trading session after the company reported fourth-quarter earnings that fell significantly short of Wall Street expectations.
In 2024, Viking reported positive results from four different clinical trials, including a Phase 2 study for subcutaneous VK2735 and a Phase 1 trial of an oral tablet form of VK2735 to treat obesity.
